85 filings
Page 2 of 5
424B3
stgqjqzqa4tt upm
13 Jul 23
Prospectus supplement
4:32pm
EFFECT
te16xch31o3
11 Jul 23
Notice of effectiveness
12:15am
CORRESP
2jl9j r5wqiy
6 Jul 23
Correspondence with SEC
12:00am
UPLOAD
pzczqm
5 Jul 23
Letter from SEC
12:00am
8-K
pw2vunu inagp9
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:44pm
424B3
8ay308z
18 May 23
Prospectus supplement
4:15pm
424B5
0d0fto
17 May 23
Prospectus supplement for primary offering
4:25pm
8-K
qtadt6zccaz 07
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
ARS
gsp4die4ona7u89h uoy
27 Apr 23
Annual report to shareholders
4:16pm
DEFA14A
wyspv7ubl6u02y4cqu
27 Apr 23
Additional proxy soliciting materials
4:14pm
PRE 14A
ebkxv09sy96vjso
17 Apr 23
Preliminary proxy
4:05pm
8-K
8qs5bydz6hj691
16 Mar 23
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
7:22am
S-8
0dsq4g9e916h7r43
15 Mar 23
Registration of securities for employees
5:31pm
8-K
hooui v01fj
14 Nov 22
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
7:11am